Stevens, David
Lane, Deirdre A.
Harrison, Stephanie L.
Lip, Gregory Y. H.
Kolamunnage-Dona, Ruwanthi
Article History
Received: 24 July 2021
Accepted: 15 November 2021
First Online: 18 December 2021
Declarations
:
: Not applicable.
: Not applicable.
: DS and RKD: None declared.DAL: Received investigator-initiated educational grants from Bristol-Myers Squibb (BMS), has been a speaker for Boehringer Ingeheim, and BMS/Pfizer and has consulted for BMS/Pfizer, Bayer, Boehringer Ingelheim, and Daiichi-Sankyo.SLH: Received investigator-initiated funding from Bristol-Myers Squibb.GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim and Daiichi-Sankyo. No fees are received personally.